Detalles de la búsqueda
1.
Lessons learned from a multi-data source research collaboration: The mirabegron post-authorization safety study program.
Pharmacoepidemiol Drug Saf
; 33(5): e5799, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38680102
2.
Anticholinergic exposure and its association with dementia/Alzheimer's disease and mortality in older adults.
BMC Geriatr
; 23(1): 401, 2023 06 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37391728
3.
A prospective study of elderly initiating mirabegron versus antimuscarinics: Patient reported outcomes from the Overactive Bladder Satisfaction Scales and other instruments.
Neurourol Urodyn
; 37(1): 177-185, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28370541
4.
A retrospective, matched cohort study of potential drug-drug interaction prevalence and opioid utilization in a diabetic peripheral neuropathy population initiated on pregabalin or duloxetine.
BMC Health Serv Res
; 15: 159, 2015 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25889173
5.
Impact of a pregabalin step therapy policy among medicare advantage beneficiaries.
Pain Pract
; 14(5): 419-26, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23701733
6.
Heart Failure Among Patients with Multiple Myeloma Treated with Carfilzomib-Based Versus Non-Carfilzomib-Based Regimens in the United States by Race.
Clin Lymphoma Myeloma Leuk
; 23(8): 616-625, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37258396
7.
Retrospective evaluation of an inpatient psychiatric pharmacist consultation service.
J Am Pharm Assoc (2003)
; 51(5): 599-604, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21896457
8.
Removal of prior authorization for medication-assisted treatment: impact on opioid use and policy implications in a Medicare Advantage population.
J Manag Care Spec Pharm
; 27(5): 596-606, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33908274
9.
Real-world treatment, clinical outcomes and healthcare resource utilization among persons with hemophilia A by age.
J Comp Eff Res
; 10(15): 1121-1131, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34240615
10.
Novel Approach Using Administrative Claims to Evaluate Trends in Oncology Multigene Panel Testing for Patients Enrolled in Medicare Advantage Health Plans.
JCO Precis Oncol
; 52021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34036226
11.
Cardiovascular Risk in Users of Mirabegron Compared with Users of Antimuscarinic Treatments for Overactive Bladder: Findings from a Non-Interventional, Multinational, Cohort Study.
Drug Saf
; 44(8): 899-915, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34236595
12.
A study of cancer occurrence in users of mirabegron and antimuscarinic treatments for overactive bladder.
Curr Med Res Opin
; 37(5): 867-877, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33591859
13.
The Relationship Between Anticholinergic Exposure and Falls, Fractures, and Mortality in Patients with Overactive Bladder.
Drugs Aging
; 36(10): 957-967, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31359329
14.
Impact of Coexisting Overactive Bladder in Medicare Patients With Dementia on Clinical and Economic Outcomes.
Am J Alzheimers Dis Other Demen
; 34(7-8): 492-499, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30966757
15.
An Evaluation of Longitudinal Measures of Anticholinergic Exposure for Application in Retrospective Administrative Data Analyses.
Adv Ther
; 36(9): 2247-2259, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31385284
16.
Adherence and economic impact of paliperidone palmitate versus oral atypical antipsychotics in a Medicare population.
J Comp Eff Res
; 7(8): 723-735, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29722547
17.
Impact of coexisting overactive bladder in Medicare patients with osteoporosis.
Arch Gerontol Geriatr
; 75: 44-50, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29180131
18.
Healthcare utilization and costs with fixed-source versus variable-source tacrolimus in patients receiving a kidney transplant.
J Med Econ
; 21(11): 1067-1074, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-30032686
19.
Association of obesity with healthcare resource utilization and costs in a commercial population.
Curr Med Res Opin
; 34(7): 1335-1343, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29649917
20.
Impact of 2015 Update to the Beers Criteria on Estimates of Prevalence and Costs Associated with Potentially Inappropriate Use of Antimuscarinics for Overactive Bladder.
Drugs Aging
; 34(7): 535-543, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28540648